Suggestions
Sebastian Eriksson Giwa, PhD
Founder of Sylvatica Biotech, Ossium Health, Elevian Inc, Expanse Bio and the Organ Preservation Alliance
Sebastian Eriksson Giwa, PhD is the Founder, Chairman & CEO of Sylvatica Biotech Inc, a company focused on transforming organ transplantation, drug discovery, and regenerative medicine through advanced preservation technologies.12 He has an extensive background in biotechnology entrepreneurship and scientific research.
Giwa holds a PhD in Game theory, behavioral economics, and experimental economics from the Stockholm School of Economics, and an MBA with High Distinction from Harvard Business School, where he was named a Baker Scholar.1 He has also completed graduate studies at MIT, Harvard University, and Singularity University.1
Throughout his career, Giwa has founded several biotech companies:
- Sylvatica Biotech Inc (2019-present): Developing preservation technology to extend the useful life of transplant organs.3
- Elevian, Inc. (2017-present): Serving as Founding Executive Chairman and later Chairman.1
- Ossium Health (2014-2018): Founded and served as CEO and Executive Chairman.13
- Organ Preservation Alliance (2012-2017): Founded and served as CEO, then Chairman.13
Giwa's work focuses on solving the organ transplantation crisis by improving organ preservation methods. His research has demonstrated success in freezing and thawing human livers while maintaining their functionality.3 The goal is to extend organ preservation time from a few hours to days or possibly longer, potentially revolutionizing the field of organ transplantation.3
In addition to his entrepreneurial ventures, Giwa has experience in finance and consulting, having worked at Bridgewater Associates, Bain & Company, and Goldman Sachs.1 He has also been involved in policy advocacy, speaking at events such as the White House Organ Summit in 2016.3
Highlights



